New Study – Dermatologicals in Greece 2015

hair loss research The performance of dermatologicals in 2014, which saw value sales increase by 7%, was attributable to the fact that the category is recovering from the acute declines recorded in the recent past, as well as to the wave of switches that took place during 2014, enlarging considerably the list of OTC dermatologicals – for instance, antipruritics, which had been exclusively Rx, switched to OTC in 2014. In addition, certain dermatologicals, such as antiparasitics/lice (head and body) treatments and topical allergy remedies/antihistamines, benefited as seasonal demand was high.

Competitive Landscape

Johnson & Johnson Hellas SA continued to lead dermatologicals in Greece during 2014, with a retail value share of 35%. The company’s strong position in dermatologicals was attributable mainly to the strength of its brands Regaine in hair loss treatments, Daktarin in topical antifungals and Johnson’s Baby and Penaten in nappy (diaper) rash treatments. The company also leads in medicated shampoos, with its Fungoral brand.

Full Report Details at
– http://www.fastmr.com/prod/974592_dermatologicals_in_greece.aspx?afid=101

Industry Prospects

Sales of dermatologicals are expected to increase moderately over the forecast period, with no dramatic developments expected.

Dermatologicals is expected to increase in constant value at a CAGR of 4% between 2004 and 2008, with value for money likely to be the key trend in the category, as Greek consumers are set to remain very price sensitive, although not excessively so, as quality and efficacy remain the leading determinants of the purchasing decision in dermatologicals.

The wave of recent switches opens up a whole new area for companies, which will now be able to advertise and promote their previously Rx products. Anticipated unit price increases after the January 2017 price liberalisation will contribute to value growth.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Greece with research from Euromonitor’s team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you’re in the Medicated Skin Care industry in Greece, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Greece market research report includes:

* Analysis of key supply-side and demand trends
* Detailed segmentation of international and local products
* Historic volumes and values, company and brand market shares
* Five year forecasts of market trends and market growth
* Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

* What is the market size of Medicated Skin Care in Greece?
* What are the major brands in Greece?
* What are the most popular formats for acne treatments?

Reasons to Get this Report

* Gain competitive intelligence about market leaders
* Track key industry trends, opportunities and threats
* Inform your marketing, brand, strategy and market development, sales and supply functions

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world’s top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available.  Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com

Source

 

Posted in: